Galactogogue
发表于 2025-3-23 11:06:09
Case Study #4: Lutathera, a Gold Standard for Peptide Receptor Radiopharmaceutical Therapyata from the most important work in this field, the phase III NETTER-1 trial, which showed that the treatment of unresectable/metastatic progressive small bowel NETs with Lutathera. resulted in a significant improvement in progression-free survival (PFS) and overall survival (OS) compared with high-
接合
发表于 2025-3-23 14:03:50
http://reply.papertrans.cn/83/8209/820888/820888_12.png
Mettle
发表于 2025-3-23 21:02:39
http://reply.papertrans.cn/83/8209/820888/820888_13.png
形容词词尾
发表于 2025-3-24 01:44:22
http://reply.papertrans.cn/83/8209/820888/820888_14.png
包租车船
发表于 2025-3-24 02:39:42
Book 2023eview process for radiotherapeutics..This book is the first of its kind andis useful for a broad audience of scientists, researchers, physicians, and students across a range of fields, including biochemistry, cancer biology, nuclear medicine, radiology, and radiation oncology..
尽管
发表于 2025-3-24 07:57:48
http://reply.papertrans.cn/83/8209/820888/820888_16.png
VERT
发表于 2025-3-24 13:59:04
Ganesan Vaidyanathan,Yutian Feng,Michael R. Zalutsky
Femish
发表于 2025-3-24 15:05:44
http://reply.papertrans.cn/83/8209/820888/820888_18.png
性冷淡
发表于 2025-3-24 23:00:17
Nai-Kong V. Cheung,Kim Kramer,Shakeel Modak,Brian H. Kushner,Mahiuddin Ahmed,Brian Santich,Sarah Che
生气地
发表于 2025-3-24 23:34:41
http://reply.papertrans.cn/83/8209/820888/820888_20.png